DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/9zc9zn/europe) has announced the addition of the "Europe Pharmaceutical & Healthcare Reports" report to their offering.
The Europe Pharmaceuticals & Healthcare Reports feature independent forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.
Europe Pharmaceuticals and Healthcare Reports are a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, together with a comprehensive statistical appendix.
Reasons To Buy
These reports provide industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the pharmaceutical and healthcare industry.
Use these original and insightful reports to...
- Assess future market values with our unique and regularly reviewed independent 5-year market forecasts.
- Track the latest developments with the news service that is included for every country.
- Understand the critical issues and drivers which are shaping the market.
- Evaluate the environment for branded and generic operators and stay in touch with the fast growing biologic sector.
- Shape and support business plans and decisions with reliable business data.
- Benchmark key market performance with Espicom's standardised data.
For more information visit http://www.researchandmarkets.com/research/9zc9zn/europe




